Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmer, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmer, L. A.
The Proceedings of the American Thoracic Society 3:166-169 (2006)
© 2006 The American Thoracic Society

Regulation of Respiration and Endothelial Gene Expression by S-Nitrosothiols in Health and Disease

Lisa A. Palmer

Department of Pediatrics and Anesthesiology, University of Virginia Health System, Charlottesville, Virginia

Correspondence and requests for reprints should be addressed to Lisa A. Palmer, Ph.D., Department of Pediatrics, P.O. Box 801366, University of Virginia, Charlottesville, VA 22908. E-mail: lap5w{at}virginia.edu

ABSTRACT

The effects of nitric oxide (NO) are mediated by cyclic guanosine monophosphate (cGMP)-dependent and cGMP-independent processes. Most cGMP-independent effects are mediated by the actions of S-nitrosothiols (SNOs). SNOs have been shown to play a role in health and in disease. In studies performed in the mouse and rat, the ventilatory response to hypoxia is regulated in the nucleus tractus solitarius by SNOs exported from red blood cells. This may affect the treatment of respiratory distress in newborns and sleep apnea in adults. Likewise, SNOs have been shown to alter the stability and abundance of the transcription factor hypoxia inducible factor-1, altering the expression of hypoxia-regulated genes. Identification of the proteins involved in these signaling events will lead to new therapeutic approaches in the treatment of diseases characterized by limited oxygen availability.

Key Words: {gamma} glutamyl transpeptidase • hypoxia inducible factor-1 • S-nitrosothiols







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Thoracic Society.
 
CCM abstracts